$41.30
-0.17-0.41%
After Hours: 6:19 AM EDT
Comments
Loading...
Mirum Pharmaceuticals Insider Trading Activity | NASDAQ:MIRM | Benzinga
Track the latest Mirum Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Mirum Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Mirum Pharmaceuticals Inc Insiders Doing?
At Mirum Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.42K shares worth $107.34K, meanwhile, insiders have reported buying a total of 2.85K shares for a total value of $123.73K.
Notable Recent Insider Buys and Sales
- On March 12, 2025, Patrick J Heron, the company's - purchased 2.3K shares for $43.31 each.
- On March 10, 2025, Patrick J Heron, the company's - purchased 1.92K shares for $43.69 each.
- On March 6, 2025, Patrick J Heron, the company's - purchased 1.6K shares for $45.4 each.
Ownership Statistics for Mirum Pharmaceuticals Inc
Shares Outstanding
49.014M
Insider Shares Owned
426.227K
Insider Percentage Owned
0.87%
Institutional Shares Held
28.761M
Institutional Percentage Held
58.7%
| Mar 19, 2025 | Jolanda Howe | SVP, GLOBAL CONTROLLER | -2.42K | $44.45 | -$107.34K | SELL | -49.89% | 2.43K | Mar 18 | View |
| Mar 18, 2025 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 609.00 | $23.64 | -$2.40M | SELL-OPTIONS | 14.39% | 4.84K | Mar 15 - Mar 17 | View |
| Mar 18, 2025 | Peter Radovich | PRESIDENT AND COO | 6.56K | $44.21 | -$348.36K | SELL-OPTIONS | 54.17% | 18.67K | Mar 15 - Mar 17 | View |
| Mar 18, 2025 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 22.72K | $44.21 | -$1.21M | SELL-OPTIONS | 7.00% | 347.21K | Mar 15 - Mar 17 | View |
| Mar 18, 2025 | Patrick J Heron | — | 549.00 | $44.11 | $24.21K | BUY | 0.01% | 3.74M | Mar 14 - Mar 17 | View |
| Mar 12, 2025 | Patrick J Heron | — | 2.30K | $43.31 | $99.52K | BUY | 0.06% | 3.74M | Mar 10 - Mar 11 | View |
| Mar 10, 2025 | Patrick J Heron | — | 1.92K | $43.69 | $83.66K | BUY | 0.05% | 3.73M | Mar 06 - Mar 07 | View |
| Mar 06, 2025 | Patrick J Heron | — | 1.60K | $45.40 | $72.72K | BUY | 0.04% | 3.73M | Mar 04 - Mar 05 | View |
| Mar 05, 2025 | Peter Radovich | PRESIDENT AND COO | -14.85K | $45.58 | -$676.93K | SELL | -55.08% | 12.11K | Mar 04 | View |
| Mar 04, 2025 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 0.00 | $24.92 | -$1.76M | SELL-OPTIONS | 0.00% | 324.49K | Mar 03 | View |
| Feb 04, 2025 | Peter Radovich | PRESIDENT AND COO | -2.63K | $48.22 | -$126.68K | SELL | -8.88% | 26.96K | Feb 03 | View |
| Feb 04, 2025 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -9.10K | $48.22 | -$438.92K | SELL | -2.73% | 324.49K | Feb 03 | View |
| Feb 04, 2025 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 708.00 | $48.22 | -$51.31K | SELL-OPTIONS | 20.09% | 4.23K | Jan 31 - Feb 03 | View |
| Jan 27, 2025 | Peter Radovich | PRESIDENT AND COO | 2.57K | $47.92 | -$152.26K | SELL-OPTIONS | 9.52% | 29.59K | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 598.00 | $47.92 | -$43.23K | SELL-OPTIONS | 20.44% | 3.52K | Jan 23 - Jan 24 | View |
| Jan 27, 2025 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 5.66K | $47.92 | -$327.66K | SELL-OPTIONS | 1.73% | 333.59K | Jan 23 - Jan 24 | View |
| Jan 21, 2025 | Joanne Quan | CHIEF MEDICAL OFFICER | 5.53K | $45.86 | -$319.60K | SELL-OPTIONS | 4687.29% | 5.65K | Jan 16 - Jan 17 | View |
| Jan 08, 2025 | Peter Radovich | PRESIDENT AND COO | -2.00K | $42.82 | -$85.54K | SELL | -6.89% | 27.02K | Jan 07 | View |
| Jan 08, 2025 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -7.49K | $42.82 | -$320.64K | SELL | -2.23% | 327.93K | Jan 07 | View |
| Jan 08, 2025 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 500.00 | $42.82 | -$32.11K | SELL-OPTIONS | 20.61% | 2.93K | Jan 06 - Jan 07 | View |
| Nov 15, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 0.00 | $25.02 | -$110.40K | SELL-OPTIONS | 0.00% | 2.43K | Nov 14 | View |
| Sep 20, 2024 | Patrick Heron | — | 115.00 | $37.40 | $4.30K | BUY | 0.00% | 3.73M | Sep 18 | View |
| Sep 10, 2024 | Patrick Heron | — | 230.00 | $41.58 | $9.56K | BUY | 0.01% | 3.73M | Sep 06 | View |
| Jul 03, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 667.00 | $34.00 | -$12.75K | SELL-OPTIONS | 37.92% | 2.43K | Jul 01 - Jul 02 | View |
| Jun 25, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 0.00 | $18.47 | -$949.28K | SELL-OPTIONS | 0.00% | 102.41K | Jun 24 | View |
| Jun 07, 2024 | Saira Ramasastry | — | 0.00 | $19.90 | -$57.80K | SELL-OPTIONS | 0.00% | 0.00 | Jun 05 | View |
| Mar 27, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2.00K | $24.80 | $49.60K | BUY | 16.67% | 14.00K | Mar 27 | View |
| Mar 25, 2024 | Peter Radovich | PRESIDENT AND COO | -4.30K | $25.80 | -$111.02K | SELL | -12.92% | 29.01K | Mar 25 | View |
| Mar 18, 2024 | Peter Radovich | PRESIDENT AND COO | -1.38K | $20.62 | -$28.44K | SELL | -3.97% | 33.32K | Jan 09 | View |
| Mar 18, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.38K | $20.62 | -$28.44K | SELL | -1.33% | 102.31K | Jan 09 | View |
| Mar 18, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -38.00 | $15.63 | -$10.42K | SELL | -0.04% | 104.37K | Sep 10 - Jan 09 | View |
| Mar 18, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -5.16K | $20.62 | -$106.39K | SELL | -1.69% | 300.52K | Jan 09 | View |
| Mar 18, 2024 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 2.00K | $25.80 | $51.60K | BUY | 20.00% | 12.00K | Mar 18 | View |
| Feb 05, 2024 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | -1.21K | $26.19 | -$31.80K | SELL | -1.16% | 103.69K | Feb 02 | View |
| Feb 05, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -847.00 | $26.19 | -$22.18K | SELL | -0.80% | 104.41K | Feb 02 | View |
| Feb 05, 2024 | Peter Radovich | PRESIDENT AND COO | -1.79K | $26.19 | -$46.88K | SELL | -4.91% | 34.70K | Feb 02 | View |
| Feb 05, 2024 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | -6.01K | $26.19 | -$157.49K | SELL | -1.93% | 305.68K | Feb 02 | View |
| Feb 02, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1.04K | $26.19 | -$19.25K | SELL-OPTIONS | 143.63% | 1.76K | Jan 31 - Feb 02 | View |
| Jan 09, 2024 | Peter Radovich | CHIEF OPERATING OFFICER | -1.41K | $28.03 | -$39.47K | SELL | -3.72% | 36.48K | Jan 08 | View |
| Jan 09, 2024 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -1.02K | $28.04 | -$28.57K | SELL | -0.96% | 105.25K | Jan 08 | View |
| Jan 09, 2024 | Pamela Vig | HEAD OF RESEARCH & DEVELOPMENT | -1.41K | $28.03 | -$39.47K | SELL | -1.32% | 104.91K | Jan 08 | View |
| Jan 09, 2024 | Christopher Peetz | PRESIDENT AND CEO | -5.21K | $28.03 | -$146.03K | SELL | -1.64% | 311.69K | Jan 08 | View |
| Jan 09, 2024 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 722.00 | $28.04 | -$14.80K | SELL-OPTIONS | ∞ | 722.00 | Jan 06 - Jan 08 | View |
| Dec 06, 2023 | Jody Howe | SVP, GLOBAL CONTROLLER | 0.00 | $17.67 | -$73.65K | SELL-OPTIONS | 0.00% | 0.00 | Dec 05 | View |
| Nov 14, 2023 | Patrick Heron | DIRECTOR | 2.91K | $28.30 | $82.35K | BUY | 0.08% | 3.73M | Nov 09 | View |
| Sep 15, 2023 | Patrick Heron | DIRECTOR | 2.63K | $31.02 | $81.42K | BUY | 0.07% | 3.73M | Sep 13 | View |
| Sep 14, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $17.47 | -$424.57K | SELL-OPTIONS | 0.00% | 93.75K | Sep 13 - Sep 14 | View |
| Sep 13, 2023 | Patrick Heron | DIRECTOR | 8.44K | $30.44 | $256.79K | BUY | 0.23% | 3.72M | Sep 11 - Sep 12 | View |
| Sep 12, 2023 | ERIC BJERKHOLT | CHIEF FINANCIAL OFFICER | 10.00K | $29.65 | $296.49K | BUY | ∞ | 10.00K | Sep 11 | View |
| Sep 05, 2023 | Patrick Heron | DIRECTOR | 147.99K | $26.25 | $3.88M | BUY | 4.15% | 3.71M | Aug 31 | View |
| Aug 28, 2023 | Jody Howe | SVP, GLOBAL CONTROLLER | -3.46K | $26.23 | -$90.74K | SELL | -100.00% | 0.00 | Aug 25 | View |
| Jul 05, 2023 | Peter Radovich | CHIEF OPERATING OFFICER | -1.43K | $25.65 | -$36.55K | SELL | -3.64% | 37.67K | Jul 03 | View |
| Jul 05, 2023 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | -1.00K | $25.65 | -$25.75K | SELL | -0.94% | 105.84K | Jul 03 | View |
| Jul 05, 2023 | Pamela Vig | HEAD RESEARCH & DEVELOPMENT | -1.43K | $25.65 | -$36.55K | SELL | -1.33% | 105.79K | Jul 03 | View |
| Jul 05, 2023 | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1.69K | $25.65 | -$23.47K | SELL-OPTIONS | 95.53% | 3.46K | Jun 30 - Jul 03 | View |
| Jul 05, 2023 | Christopher Peetz | PRESIDENT AND CEO | -5.50K | $25.65 | -$141.01K | SELL | -1.71% | 316.90K | Jul 03 | View |
| Jun 09, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $15.97 | -$380.74K | SELL-OPTIONS | 0.00% | 93.75K | Jun 08 | View |
| May 04, 2023 | MICHAEL GREY | DIRECTOR | 0.00 | $15.47 | -$366.13K | SELL-OPTIONS | 0.00% | 93.75K | May 03 | View |
| Nov 15, 2022 | Niall O'Donnell Attorney-in-Fact | DIRECTOR | -300.00K | $19.86 | -$5.96M | SELL | -15.62% | 1.62M | Nov 11 - Nov 15 | View |
| Jun 08, 2022 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LP | 10% OWNER | -38.48K | $25.01 | -$962.26K | SELL | -2.44% | 1.54M | Jun 06 | View |
| Nov 29, 2021 | Ian Clements | CHIEF FINANCIAL OFFICER | 1.45K | $14.14 | $20.50K | BUY | 8.47% | 18.56K | Nov 24 - Nov 26 | View |
| Nov 29, 2021 | Christopher Peetz | PRESIDENT AND CEO | 7.00K | $14.40 | $100.80K | BUY | 3.14% | 229.60K | Nov 24 | View |
| Oct 01, 2021 | Christopher Peetz | PRESIDENT AND CEO | 18.20K | $19.26 | -$70.71K | GRANT | 8.91% | 222.60K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 8.68% | 84.67K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Ian Clements | CHIEF FINANCIAL OFFICER | 7.80K | $19.26 | -$30.31K | GRANT | 88.13% | 16.65K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Lara Longpre | CHIEF DEVELOPMENT OFFICER | 7.16K | $19.26 | -$18.51K | GRANT | 9.29% | 84.25K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Peter Radovich | CHIEF OPERATING OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 149.84% | 11.27K | Sep 29 - Oct 01 | View |
| Oct 01, 2021 | Jonathan Edwin Tucker | CHIEF MEDICAL OFFICER | 6.76K | $19.26 | -$26.26K | GRANT | 17.33% | 45.77K | Sep 29 - Oct 01 | View |
| Jul 13, 2021 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LPDeerfield Mgmt LPDeerfield Special Situations Fund LP | 10% OWNER | -99.33K | $15.81 | -$1.57M | SELL | -5.45% | 1.72M | Jul 09 | View |
| Jul 07, 2021 | James FlynnDeerfield Mgmt HIF LPDeerfield Mgmt IV LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Private Design Fund IV LPDeerfield Healthcare Innovations Fund LPDeerfield Mgmt LPDeerfield Special Situations Fund LP | 10% OWNER | -66.67K | $16.29 | -$1.09M | SELL | -3.53% | 1.82M | Jul 02 - Jul 07 | View |
| Dec 28, 2020 | Ian Clements | — | 2.47K | $18.61 | $45.97K | PURCHASE | 45.99% | 7.84K | Dec 23 | View |
| Dec 28, 2020 | Christopher Peetz | — | 5.00K | $18.70 | $93.48K | PURCHASE | 2.53% | 202.94K | Dec 23 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.